tiprankstipranks
Minerva Neurosciences (NERV)
NASDAQ:NERV

Minerva Neurosciences (NERV) Income Statement

556 Followers

Minerva Neurosciences Income Statement

Last quarter (Q4 2023), Minerva Neurosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Minerva Neurosciences's net income was $-9.02M. See Minerva Neurosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 41.18M$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 23.12M$ 23.12M$ -25.23M$ -45.37M$ 39.33M$ 75.87M
Operating Income
$ -23.12M$ -23.12M$ -25.23M$ -51.69M$ 1.85M$ -75.87M
Net Non Operating Interest Income Expense
$ 1.44M$ 1.44M$ -6.85M$ 16.52K$ 0.00$ 0.00
Other Income Expense
---$ -15.20M$ 94.02K$ 1.43M
Pretax Income
$ -21.72M$ -21.72M$ -32.11M$ -51.71M$ 1.94M$ -74.44M
Tax Provision
---$ -1.80M$ 0.00$ -2.25M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -30.01M$ -30.01M$ -32.11M$ -49.91M$ 1.94M$ -72.18M
Basic EPS
$ -4.65$ -4.61$ -6.01$ -1.17$ 0.05$ -1.85
Diluted EPS
$ -4.65$ -4.61$ -6.01$ -1.17$ 0.05$ -1.85
Basic Average Shares
$ 26.03M$ 6.51M$ 5.34M$ 42.72M$ 40.82M$ 39.01M
Diluted Average Shares
$ 26.03M$ 6.51M$ 5.34M$ 42.72M$ 40.92M$ 39.01M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
----$ -0.73-
Reported Normalized Diluted E P S
----$ -0.72-
Rent Expense Supplemental
------
Total Expenses
$ 23.12M$ 23.12M$ -25.23M$ -45.37M$ 39.33M$ 75.87M
Net Income From Continuing And Discontinued Operation
$ -30.01M$ -30.01M$ -32.11M$ -49.91M$ 1.94M$ -72.18M
Normalized Income
$ -13.22M$ -17.16M--$ 1.85M$ -73.57M
Interest Expense
----$ 0.00$ 0.00
EBIT
$ -21.72M$ -21.72M$ -24.70M$ -51.71M$ 1.94M$ -75.87M
EBITDA
$ -17.54M$ -21.69M$ -24.69M$ -51.61M$ 2.12M$ -75.70M
Currency in USD

Minerva Neurosciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis